Literature DB >> 15560072

Investigation of tumor-derived extracellular DNA in blood of cancer patients by methylation-specific PCR.

Elena Y Rykova1, Tatyana E Skvortsova, Pavel P Laktionov, Svetlana N Tamkovich, Olga E Bryzgunova, Andrey V Starikov, Nina P Kuznetsova, Sergei A Kolomiets, Natalia V Sevostianova, Valentin V Vlassov.   

Abstract

The frequency of APC, RASSF1A, RARbeta, CDH1 and CDH13 gene promoter methylation in samples of DNA isolated from breast and lung patient plasma was studied in order to develop the noninvasive tumor-specific DNA detection method. Methylation of at least one of genes was detected in extracellular DNA from most of the cancer blood specimens. The results obtained indicate that promoter hypermethylation of a number of marker genes represents a promising serum marker for early breast and lung cancer detection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15560072     DOI: 10.1081/NCN-200026031

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  13 in total

1.  Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.

Authors:  Giuseppe Pelosi; Elisabetta Schianchi; Patrizia Dell'orto; Giulia Veronesi; Lorenzo Spaggiari; Felice Pasini; Gabriella Sozzi; Elisabeth Brambilla; Claudia Griso; Giuseppe Viale
Journal:  Virchows Arch       Date:  2005-09-29       Impact factor: 4.064

Review 2.  DNA methylation based biomarkers in non-invasive cancer screening.

Authors:  N Shivapurkar; A F Gazdar
Journal:  Curr Mol Med       Date:  2010-03       Impact factor: 2.222

Review 3.  "Liquid biopsy"-ctDNA detection with great potential and challenges.

Authors:  Mingwei Ma; Hongcheng Zhu; Chi Zhang; Xinchen Sun; Xianshu Gao; Gang Chen
Journal:  Ann Transl Med       Date:  2015-09

Review 4.  Methylation of cell-free circulating DNA in the diagnosis of cancer.

Authors:  Kristina Warton; Goli Samimi
Journal:  Front Mol Biosci       Date:  2015-04-22

5.  Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.

Authors:  Dan Zhou; Weiwei Tang; Wenyi Wang; Xiaoyan Pan; Han-Xiang An; Yun Zhang
Journal:  PeerJ       Date:  2016-07-14       Impact factor: 2.984

6.  APC gene promoter aberrant methylation in serum as a biomarker for breast cancer diagnosis: A meta-analysis.

Authors:  Xiaojun Qian; Liwei Ruan
Journal:  Thorac Cancer       Date:  2018-01-03       Impact factor: 3.500

Review 7.  The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review.

Authors:  Ian A Cree; Lesley Uttley; Helen Buckley Woods; Hugh Kikuchi; Anne Reiman; Susan Harnan; Becky L Whiteman; Sian Taylor Philips; Michael Messenger; Angela Cox; Dawn Teare; Orla Sheils; Jacqui Shaw
Journal:  BMC Cancer       Date:  2017-10-23       Impact factor: 4.430

8.  Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer.

Authors:  Hong Wang; Bingfeng Zhang; Dan Chen; Wenying Xia; Jiexin Zhang; Fang Wang; Jian Xu; Yan Zhang; Meijuan Zhang; Lixia Zhang; Yachun Lu; Yan Geng; Peijun Huang; Puwen Huang; Hong Wang; Shiyang Pan
Journal:  Clin Epigenetics       Date:  2015-11-05       Impact factor: 6.551

9.  Quantitative assessment of the diagnostic role of APC promoter methylation in non-small cell lung cancer.

Authors:  Shicheng Guo; Lixing Tan; Weilin Pu; Junjie Wu; Kuan Xu; Jinhui Wu; Qiang Li; Yanyun Ma; Jibin Xu; Li Jin; Jiucun Wang
Journal:  Clin Epigenetics       Date:  2014-03-24       Impact factor: 6.551

10.  Quantitative assessment of the association between APC promoter methylation and breast cancer.

Authors:  Keli He; Li Zhang; Xinghua Long
Journal:  Oncotarget       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.